Centene to offer terminations to some employees
Sheldon Cooper | Light rocket | fake images rye said it offered buyouts to some employees on Monday, as the…
Biotechnology and pharmaceuticals
Chan Zuckerberg Biohub to open new round of funding for rare diseases
Biohub, a nonprofit research organization funded by the Chan Zuckerberg Initiative, announced Thursday that it will open another round of…
Estrogen patches in short supply as women seek menopause support
Woman applying estrogen patch during hormone therapy. Half point images | Moment | fake images Estrogen patches are in short…
This life sciences stock has a secret weapon and AI will only make it more valuable
IQVIA, with its vast trove of health information, is at the center of drug development, providing data, tools and services…
What's next for the weight-loss drug maker?
Shares in Danish biotech Zealand Pharma plunged recently after detailed data on its weight-loss drug survodutide showed much higher patient…
Huntington's disease drug maker UniQure to seek FDA approval for gene therapy
Thomas Fuller | SOPA Images | Light rocket | fake images UniQure plans to seek FDA approval for its experimental…
Biotech IPO window is open, but big pharma M&As set the pace: bankers
Public markets are beginning to reopen for biotech companies after several years of subdued activity. But stronger companies are still…
Lilly, Novo and Pfizer seek new weight loss drugs
Drug makers have only been introducing GLP-1 pills for a few months and are undergoing big changes to the way…
CVS Health Executives on Reducing Healthcare's Biggest Pain Points
Nikolas Kokovlis | Nurfoto | fake images A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing…
Novo Nordisk and Eli Lilly launch anti-obesity pills and prepare for Medicare coverage
Nordisk and Eli Lilly They took their battle against the GLP-1 pill to the biggest meeting on obesity this weekend…